Indisuan Pharmaceuticals Private Limited, a active foreign private limited company, was established on 28 March 2018 in Navi Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MH2018FTC307297. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Jawed Zia (Additional Director), Amol Pramod Salvi (Additional Director). Past directors included Francisco Jose Fernandez Saniger, Harsh Vardhan Laxminarayan Pandey. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 709 A Wing, Shelton Sapphire Sector No 15, Cbd Belapur, Navi Mumbai, Maharashtra, 400614.
U51909MH2018FTC307297
307297
28 March 2018
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Indisuan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jawed Zia | Additional Director | 31 Jan 2025 | Current |
| Amol Pramod Salvi | Additional Director | 07 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Feb 2025 | Past |
| Pramod Abcsdd | Director | 15 Apr 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indisuan Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 79.1% increase. The company also saw a substantial improvement in profitability, with a 4573.8% increase in profit. The company's net worth Soared by an impressive increase of 485.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Indisuan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Indisuan Pharmaceuticals has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indisuan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indisuan Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Amol Pramod Salvi was appointed as a Additional Director was appointed as a Additional Director on 07 Apr 2025 & has been associated with this company since 7 months 26 days . was recorded as a recent event.
Progress on Jawed Zia was appointed as a Additional Director was appointed as a Additional Director on 31 Jan 2025 & has been associated with this company since 10 months . was documented.
Progress on Indisuan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Indisuan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Indisuan Pharmaceuticals Private Limited was registered on 28 Mar 2018 with Roc Mumbai & aged 7 years 8 months as per MCA records. was completed.
The CIN of Indisuan Pharmaceuticals Private Limited is U51909MH2018FTC307297.
Indisuan Pharmaceuticals Private Limited is headquartered at 709 A Wing, Shelton Sapphire Sector No 15, Cbd Belapur, Navi Mumbai, Maharashtra, 400614.
Indisuan Pharmaceuticals Private Limited was incorporated on 28 March 2018.
The current directors of Indisuan Pharmaceuticals Private Limited are
The primary industry of Indisuan Pharmaceuticals Private Limited is Trade.
Indisuan Pharmaceuticals Private Limited is unlisted.
The authorized capital of Indisuan Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Indisuan Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX